Stay updated on 24H Alteplase in Ischemic Stroke Clinical Trial
Sign up to get notified when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.

Latest updates to the 24H Alteplase in Ischemic Stroke Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA 403 Forbidden error page is now shown for the study record, replacing the previous content and navigation with a standard error page. This makes the study details temporarily inaccessible on that URL.SummaryDifference17%

- Check43 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, representing a new revision of the ClinicalTrials.gov entry. This update likely includes small backend or formatting adjustments without altering the study details.SummaryDifference0.1%

- Check65 days agoChange DetectedThe sponsor's institutional name is updated to Second Affiliated Hospital, Zhejiang University, School of Medicine, reflecting the official affiliation. The revision marker is updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check79 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, signaling a newer version of the page documentation. This change reflects an administrative update to the page metadata rather than content changes.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page revision label changed from v3.6.2 to v3.6.3, indicating a newer build of the page; this reflects a software revision rather than substantive updates to trial information.SummaryDifference0.0%

Stay in the know with updates to 24H Alteplase in Ischemic Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 24H Alteplase in Ischemic Stroke Clinical Trial page.